JohnCalebBrowningSr.MD

Dermatology • San Antonio, TX

Pediatric Dermatology

Assistant Professor, Pediatrics, University of Texas Medical School, San Antonio

Join to view full profile

Dr. Browning is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Browning's full profile

Already have an account?

Office
3320 Oakwell Ct
San Antonio, TX 78218
Phone+1 210-829-5180

Fax+1 210-829-5030

Education & Training

Baylor College of MedicineResidency, Dermatology, 2004 - 2007
Baylor College of Medicine (Houston)Residency, Pediatrics, 2001 - 2004
University of Texas Medical Branch School of MedicineClass of 2001
Baylor College of MedicineFellowship, Pediatric Dermatology

Certifications & Licensure

TX State Medical License 2004 - 2027
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Start of enrollment: 2012 Jul 01
Terminated
Phase 1
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum Contagiosum Start of enrollment: 2016 Feb 01
Terminated
Phase 2
Mirvaso in Use Study Start of enrollment: 2014 Sep 01
Completed
Phase 4
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) Start of enrollment: 2015 Nov 16
Completed
Phase 3
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis Start of enrollment: 2017 Apr 21
Completed
Phase 2
Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa Start of enrollment: 2017 Mar 29
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis Start of enrollment: 2017 Sep 21
Completed
Phase 1
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis Start of enrollment: 2018 Aug 07
Completed
Phase 3
First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations Start of enrollment: 2020 Oct 01
Terminated
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata.
Mercedes E Gonzalez, John Browning, Stacy Smith, Anna Plotka, Jing Daisy Zhu
Pediatric Dermatology. 2025-02-09
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.
Eric L Simpson, Adelaide A Hebert, John Browning, Rocco T Serrao, Howard Sofen
Dermatology and Therapy. 2025-01-01
Asymptomatic CD34plaque on the scalp of a child.
Tue F Nguyen, Aeja Weiss, Emily Maxon, John C Browning, Thomas Davis
Journal of Cutaneous Pathology. 2024-10-01

Press Mentions

Texas Dermatologist Recognized for Improving the Quality of Life of a Child with Rare ConditionNovember 30th, 2022
Berdazimer Gel Beats Vehicle for Molluscum Contagiosum in Phase 3 StudyJuly 15th, 2022
Berdazimer Gel Beats Vehicle for Molluscum Contagiosum in Phase 3 StudyJuly 15th, 2022
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Other Languages

Spanish